Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer

NCT00264420 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT00264420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00264420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Pilot Trial to Study the Safety and Efficacy of Concomitant Radiotherapy and Zoledronic Acid for the Palliation of Bone Metastases From Breast Cancer, Prostate Cancer and Lung Cancer
Lead sponsor
The Cleveland Clinic
Phase
Phase 1
Overall status
Completed
Start date
December 31, 2005
Completion date
March 31, 2007
Enrollment
4 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bone metastases, breast cancer, lung cancer, prostate cancer